
In this free webinar, gain insight into method development and optimization of custom Laboratory Developed Test (LDT) assays, including critical steps identification and risk mitigation. Attendees will learn about design control, including systematic qualification of reagents, consumables and assay parameters to ensure method robustness. The featured speakers will share insights about method validation and implementation, including performance assessments (precision, sensitivity, specificity and threshold determination) against predefined acceptance criteria. Attendees will learn about proficiency testing and IVDR-compliant technical dossier preparation for CE marking.
TORONTO, May 20, 2026 /PRNewswire/ -- The implementation of the In Vitro Diagnostic Regulation (IVDR) has significantly transformed the regulatory and operational landscape for laboratories developing and using Laboratory Developed Tests (LDTs). In particular, laboratories working with custom assays must now demonstrate robust design control, clearly defined performance characteristics and comprehensive technical documentation aligned with IVDR expectations. This webinar provides a practical and end-to-end overview of the IVDR compliance process for LDTs, illustrated through a case study focused on implementing IVDR requirements for custom LDT assays.
Attendees will gain a structured understanding of how to approach method development and optimization, with an emphasis on identifying critical assay steps, understanding sources of variability and applying effective risk mitigation strategies early in the development lifecycle. The session will explore how IVDR design control principles can be applied in practice to systematically qualify reagents, consumables and assay parameters, ensuring assay robustness, reproducibility and regulatory readiness.
The webinar will also address method validation and implementation under IVDR, outlining best practices for defining performance evaluation strategies and acceptance criteria. Key validation parameters, including precision, sensitivity, specificity and threshold determination, will be discussed in the context of IVDR regulatory expectations. Through a practical case study, participants will learn to translate validation data into compliant and defensible documentation.
In addition, the session will clarify IVDR requirements for proficiency testing and provide practical guidance on preparing an IVDR-compliant technical dossier to support CE marking of custom LDT assays. Common challenges, pitfalls and lessons learned from real implementation experience will be shared to help laboratories reduce regulatory risk and avoid rework.
Register for this webinar to learn how IVDR compliance for custom LDT assays supports method validation, technical documentation and CE marking.
Join experts from Cerba Research, Lorella Di Donato, Chief Laboratory & Operations Officer; Martin Roberge, PhD, Director, Development & Innovation; and Marie-Laure Delalande, Head of IVD Operations, for the live webinar on Tuesday, June 9, 2026, at 11am EDT (5pm CEST/EU-Central).
For more information, or to register for this event, visit IVDR Process Overview with Case-study on IVDR Implementation for Custom LDT Assays.
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
Share this article